Cardiology Department, Universitary Clinic Hospital, INCLIVA. Universitat de València. Valencia, Spain; CIBER Cardiovascular, Madrid, Spain.
Cardiology Department, Universitary Clinic Hospital, INCLIVA. Universitat de València. Valencia, Spain.
Am J Cardiol. 2022 Nov 15;183:48-54. doi: 10.1016/j.amjcard.2022.08.013. Epub 2022 Sep 22.
Frailty is associated with increased mortality and hospitalizations in patients with heart failure (HF). However, there is little evidence regarding the burden of morbidity. In this study, we aimed to assess the association between frailty and recurrent all-cause HF hospitalizations in patients with stable chronic HF. This was an observational and prospective study that enrolled HF outpatients followed in a specialized HF unit of a single tertiary care center from 2017 to 2019. Frailty was assessed by Fried criteria. Robustness, prefrailty, and frailty were defined as 0, 1 to 2, and ≥3, respectively. The independent association between frailty status and recurrent hospitalizations was assessed through Famoye's bivariate Poisson regression model, and risk estimates were expressed as incidence rate ratios (IRR). A total of 277 patients were included. The mean age was 74 ± 10 years, 118 were women (42.6%), and 131 patients (47.3%) had left ventricular ejection fraction ≥50. According to Fried's score 61 patients (22%) were robust, 95 patients (34%) were prefrail, and 121 patients (44%) were frail. After a median follow-up of 2.21 (1.6 to 2.8) years, 52 patients (19%) died. We registered 348 all-cause hospitalizations in 144 patients (52%) and 178 HF hospitalizations in 108 patients (39%). Compared with robust patients, frailty was associated with a higher risk of all-cause and HF recurrent hospitalizations in multivariable analysis (IRR 2.01, 95% confidence interval 1.14 to 3.57, p = 0.017 and IRR 2.25, 95% confidence interval 1.16-4.36, p = 0.016, respectively). In conclusion, in patients with chronic HF, frailty identifies patients with an increased risk of total and recurrent all-cause and HF hospitalizations.
衰弱与心力衰竭(HF)患者的死亡率和住院率增加有关。然而,关于发病率负担的证据很少。在这项研究中,我们旨在评估稳定慢性 HF 患者中衰弱与复发性全因 HF 住院之间的关联。这是一项观察性和前瞻性研究,纳入了 2017 年至 2019 年在一家三级保健中心的专门 HF 病房就诊的 HF 门诊患者。衰弱通过 Fried 标准进行评估。稳健、前期衰弱和衰弱分别定义为 0、1 至 2 和≥3。通过 Famoye 的双变量泊松回归模型评估衰弱状态与复发性住院之间的独立关联,风险估计表示为发病率比(IRR)。共纳入 277 例患者。平均年龄为 74±10 岁,118 例为女性(42.6%),131 例(47.3%)左心室射血分数≥50。根据 Fried 评分,61 例(22%)患者为稳健,95 例(34%)为前期衰弱,121 例(44%)为衰弱。中位随访 2.21 年(1.6 至 2.8)后,52 例(19%)患者死亡。我们在 144 例患者(52%)中记录了 348 例全因住院和 108 例患者(39%)中的 178 例 HF 住院。与稳健患者相比,衰弱与多变量分析中的全因和 HF 复发性住院风险增加相关(IRR 2.01,95%置信区间 1.14 至 3.57,p=0.017 和 IRR 2.25,95%置信区间 1.16-4.36,p=0.016,分别)。总之,在慢性 HF 患者中,衰弱确定了全因和复发性全因和 HF 住院风险增加的患者。